SCHEMBL28536742

SCHEMBL28536742

COc1ccc(-c2nc(C=O)cn2C)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.50
ALDH1A1 P00352 5/20 0.42
CYP2A6 P11509 1/20 0.42
KMT2A Q03164 3/20 0.41
MEN1 O00255 2/20 0.41
PKM P14618 1/20 0.41
MDM2 Q00987 1/20 0.41
PTGS2 P35354 3/20 0.41
PTGS1 P23219 2/20 0.41
KDM4E B2RXH2 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
NLRP3 Q96P20 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
CASP3 P42574 1/20 0.40
SENP8 Q96LD8 1/20 0.40
SENP7 Q9BQF6 1/20 0.40
SENP6 Q9GZR1 1/20 0.40
CYP1A2 P05177 1/20 0.39
POLB P06746 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5418012 0.82 PTGS2 (0.57) MAPTALDH1A1KMT2AMEN1PTGS2
SCHEMBL18865676 0.81 PTGS2 (0.40) MAPTALDH1A1KMT2AMEN1PTGS2
SCHEMBL13181161 0.81 PTGS2 (0.40) PTGS2
SCHEMBL1313133 0.80 PDE3B (0.43) MAPTALDH1A1PTGS2KDM4ENPC1
SCHEMBL19529676 0.77 ALDH1A3 (0.53) MAPTALDH1A1KMT2AMEN1PKM
SCHEMBL28910170 0.74 MAPT (0.46) MAPTALDH1A1KMT2AMEN1PKM
SCHEMBL28177689 0.73 KDM4E (0.46) ALDH1A1KMT2AMEN1PTGS2PTGS1
SCHEMBL10916369 0.72 PTGS1 (0.57) MAPTALDH1A1KMT2AMEN1PTGS2
SCHEMBL8989243 0.72 PARP1 (0.44) MAPTALDH1A1CYP2A6KMT2AMEN1
SCHEMBL5415921 0.71 PTGS2 (0.53) MAPTALDH1A1KMT2AMEN1PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117396505-A Methods of treating inflammation 维鲁公司 2024-01-12 CN disclosed
CN-115379835-A Methods of treating coronavirus 维鲁公司 2022-11-22 CN disclosed
EP-4061349-A1 METHODS OF TREATING CORONAVIRUS Veru Inc. (US) 2022-09-28 EP disclosed
CN-112512522-A Compounds for the treatment of triple negative breast and ovarian cancer 田纳西大学研究基金会 2021-03-16 CN disclosed
CN-112437664-A Compounds for the treatment of pancreatic cancer 田纳西大学研究基金会 2021-03-02 CN disclosed